A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients

Antibody responses to SARS-CoV-2 may be important biomarkers for assessing the risk for viral transmission. Here the authors present serological antibody profiling results of COVID-19 patients using a new multiplex assay to show distinct kinetics and dynamics of IgG, IgM and IgA responses in patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Allison N. Grossberg, Lilia A. Koza, Aurélie Ledreux, Chad Prusmack, Hari Krishnan Krishnamurthy, Vasanth Jayaraman, Ann-Charlotte Granholm, Daniel A. Linseman
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/49ad9d0b0b924b0ea4951e73d801de03
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:49ad9d0b0b924b0ea4951e73d801de03
record_format dspace
spelling oai:doaj.org-article:49ad9d0b0b924b0ea4951e73d801de032021-12-02T10:44:18ZA multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients10.1038/s41467-021-21040-72041-1723https://doaj.org/article/49ad9d0b0b924b0ea4951e73d801de032021-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21040-7https://doaj.org/toc/2041-1723Antibody responses to SARS-CoV-2 may be important biomarkers for assessing the risk for viral transmission. Here the authors present serological antibody profiling results of COVID-19 patients using a new multiplex assay to show distinct kinetics and dynamics of IgG, IgM and IgA responses in patients with different disease severity.Allison N. GrossbergLilia A. KozaAurélie LedreuxChad PrusmackHari Krishnan KrishnamurthyVasanth JayaramanAnn-Charlotte GranholmDaniel A. LinsemanNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Allison N. Grossberg
Lilia A. Koza
Aurélie Ledreux
Chad Prusmack
Hari Krishnan Krishnamurthy
Vasanth Jayaraman
Ann-Charlotte Granholm
Daniel A. Linseman
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
description Antibody responses to SARS-CoV-2 may be important biomarkers for assessing the risk for viral transmission. Here the authors present serological antibody profiling results of COVID-19 patients using a new multiplex assay to show distinct kinetics and dynamics of IgG, IgM and IgA responses in patients with different disease severity.
format article
author Allison N. Grossberg
Lilia A. Koza
Aurélie Ledreux
Chad Prusmack
Hari Krishnan Krishnamurthy
Vasanth Jayaraman
Ann-Charlotte Granholm
Daniel A. Linseman
author_facet Allison N. Grossberg
Lilia A. Koza
Aurélie Ledreux
Chad Prusmack
Hari Krishnan Krishnamurthy
Vasanth Jayaraman
Ann-Charlotte Granholm
Daniel A. Linseman
author_sort Allison N. Grossberg
title A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
title_short A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
title_full A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
title_fullStr A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
title_full_unstemmed A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
title_sort multiplex chemiluminescent immunoassay for serological profiling of covid-19-positive symptomatic and asymptomatic patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/49ad9d0b0b924b0ea4951e73d801de03
work_keys_str_mv AT allisonngrossberg amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT liliaakoza amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT aurelieledreux amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT chadprusmack amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT harikrishnankrishnamurthy amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT vasanthjayaraman amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT anncharlottegranholm amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT danielalinseman amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT allisonngrossberg multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT liliaakoza multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT aurelieledreux multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT chadprusmack multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT harikrishnankrishnamurthy multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT vasanthjayaraman multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT anncharlottegranholm multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
AT danielalinseman multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients
_version_ 1718396760084185088